SG11202106506WA - Substituted 3-((3-aminophenyl)amino)piperidine-2,6-dione compounds, compositions thereof, and methods of treatment therewith - Google Patents
Substituted 3-((3-aminophenyl)amino)piperidine-2,6-dione compounds, compositions thereof, and methods of treatment therewithInfo
- Publication number
- SG11202106506WA SG11202106506WA SG11202106506WA SG11202106506WA SG11202106506WA SG 11202106506W A SG11202106506W A SG 11202106506WA SG 11202106506W A SG11202106506W A SG 11202106506WA SG 11202106506W A SG11202106506W A SG 11202106506WA SG 11202106506W A SG11202106506W A SG 11202106506WA
- Authority
- SG
- Singapore
- Prior art keywords
- aminophenyl
- piperidine
- amino
- substituted
- compositions
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/92—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with a hetero atom directly attached to the ring nitrogen atom
- C07D211/94—Oxygen atom, e.g. piperidine N-oxide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4545—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/92—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with a hetero atom directly attached to the ring nitrogen atom
- C07D211/98—Nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/30—Oxygen or sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/86—Oxygen and sulfur atoms, e.g. thiohydantoin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
- C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862782281P | 2018-12-19 | 2018-12-19 | |
| US201962879927P | 2019-07-29 | 2019-07-29 | |
| PCT/US2019/067090 WO2020132016A1 (en) | 2018-12-19 | 2019-12-18 | Substituted 3-((3-aminophenyl)amino)piperidine-2,6-dione compounds, compositions thereof, and methods of treatment therewith |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11202106506WA true SG11202106506WA (en) | 2021-07-29 |
Family
ID=71099150
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11202106506WA SG11202106506WA (en) | 2018-12-19 | 2019-12-18 | Substituted 3-((3-aminophenyl)amino)piperidine-2,6-dione compounds, compositions thereof, and methods of treatment therewith |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US11325889B2 (en) |
| EP (1) | EP3897635A4 (en) |
| JP (1) | JP2022514347A (en) |
| KR (1) | KR20210118828A (en) |
| CN (1) | CN113473987A (en) |
| AU (1) | AU2019404022A1 (en) |
| BR (1) | BR112021012186A2 (en) |
| CA (1) | CA3124101A1 (en) |
| IL (1) | IL284187A (en) |
| MX (1) | MX2021007475A (en) |
| SG (1) | SG11202106506WA (en) |
| TW (1) | TW202039434A (en) |
| WO (1) | WO2020132016A1 (en) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20210118816A (en) * | 2018-12-19 | 2021-10-01 | 셀진 코포레이션 | Substituted 3-((3-aminophenyl)amino)piperidine-2,6-dione compounds, compositions thereof, and methods of treatment using same |
| AU2020405129A1 (en) | 2019-12-19 | 2022-06-23 | Arvinas Operations, Inc. | Compounds and methods for the targeted degradation of androgen receptor |
| TW202216690A (en) | 2020-06-24 | 2022-05-01 | 美商西建公司 | Cereblon binding compounds, compositions thereof, and methods of treatment therewith |
| CA3182325A1 (en) | 2020-06-24 | 2021-12-30 | Matthew D. Alexander | Cereblon binding compounds, compositions thereof, and methods of treatment therewith |
| AR122725A1 (en) | 2020-06-24 | 2022-09-28 | Celgene Corp | CEREBLON JUNCTION COMPOUNDS, COMPOSITIONS THEREOF, AND METHODS OF TREATMENT THEREOF |
Family Cites Families (42)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4302485A1 (en) | 1993-01-29 | 1994-08-04 | Merck Patent Gmbh | Piperazine derivatives |
| FR2768728B1 (en) | 1997-09-19 | 1999-12-03 | Rhodia Chimie Sa | PROCESS FOR ACYLATION OF AN AROMATIC COMPOUND |
| FR2768729A1 (en) | 1997-09-19 | 1999-03-26 | Rhodia Chimie Sa | A new process for the acylation of an aromatic compound |
| US7629360B2 (en) | 1999-05-07 | 2009-12-08 | Celgene Corporation | Methods for the treatment of cachexia and graft v. host disease |
| CA2579886A1 (en) | 2004-09-09 | 2006-03-16 | Chugai Seiyaku Kabushiki Kaisha | Novel imidazolidine derivative and use thereof |
| US7576106B2 (en) | 2005-10-11 | 2009-08-18 | Chemocentryx, Inc. | Piperidine derivatives and methods of use |
| WO2007136640A2 (en) | 2006-05-16 | 2007-11-29 | Celgene Corporation | Processes for the preparation of substituted 2-(2,6-dioxopiperidin-3-yl)isoindole-1,3-dione |
| CN102510755A (en) | 2009-07-13 | 2012-06-20 | 哈佛大学校长及研究员协会 | Bifunctional stapled polypeptides and uses thereof |
| RU2434851C1 (en) * | 2010-07-22 | 2011-11-27 | Александр Васильевич Иващенко | Cyclic n,n'-diarylthioureas or n,n'-diarylureas - antagonists of androgen receptors, anti-cancer medication, method of obtaining and application |
| US8765978B2 (en) | 2010-12-16 | 2014-07-01 | Transitions Optical, Inc. | Method of making indeno-fused naphthol materials |
| CN103608333B (en) | 2011-03-10 | 2016-01-06 | 苏州开拓药业有限公司 | Androgen receptor antagonists and uses thereof |
| WO2012135284A2 (en) | 2011-03-28 | 2012-10-04 | Cornell University | Targeted protein silencing using chimeras between antibodies and ubiquitination enzymes |
| RU2666530C2 (en) | 2012-01-12 | 2018-09-11 | Йейл Юниверсити | Compounds and methods for enhanced degradation of target proteins and other polypeptides by an e3 ubiquitin ligase |
| MX368844B (en) | 2012-09-04 | 2019-10-16 | Shanghai hengrui pharmaceutical co ltd | Imidazoline derivatives, preparation methods thereof, and their applications in medicine. |
| WO2014063061A1 (en) | 2012-10-19 | 2014-04-24 | Dana-Farber Cancer Institute, Inc. | Hydrophobically tagged small molecules as inducers of protein degradation |
| US9139529B2 (en) | 2013-01-31 | 2015-09-22 | Vertex Pharmaceuticals Incorporated | Substituted quinoxalines as sodium channel modulators |
| JP6778114B2 (en) | 2014-04-14 | 2020-10-28 | アルビナス・オペレーションズ・インコーポレイテッドＡｒｖｉｎａｓ Ｏｐｅｒａｔｉｏｎｓ， Ｉｎｃ． | Imid-based proteolysis modulators and related uses |
| US20160058872A1 (en) | 2014-04-14 | 2016-03-03 | Arvinas, Inc. | Imide-based modulators of proteolysis and associated methods of use |
| RU2557235C1 (en) * | 2014-07-08 | 2015-07-20 | Александр Васильевич Иващенко | Substituted 2-thioxo-imidazolidin-4-one, and spiroanalogues thereof, anticancer active ingredient, pharmaceutical composition, medicinal product, method of treating prostate cancer |
| EP3256470B1 (en) | 2014-12-23 | 2023-07-26 | Dana-Farber Cancer Institute, Inc. | Methods to induce targeted protein degradation through bifunctional molecules |
| US9694084B2 (en) | 2014-12-23 | 2017-07-04 | Dana-Farber Cancer Institute, Inc. | Methods to induce targeted protein degradation through bifunctional molecules |
| AU2016209349B2 (en) | 2015-01-20 | 2020-05-07 | Arvinas, Inc. | Compounds and methods for the targeted degradation of the Androgen Receptor |
| AU2016232705C1 (en) | 2015-03-18 | 2021-06-17 | Arvinas, Inc. | Compounds and methods for the enhanced degradation of targeted proteins |
| GB201506871D0 (en) | 2015-04-22 | 2015-06-03 | Glaxosmithkline Ip Dev Ltd | Novel compounds |
| MX2018000360A (en) | 2015-07-10 | 2018-06-11 | Arvinas Inc | Mdm2-based modulators of proteolysis and associated methods of use. |
| US10772962B2 (en) | 2015-08-19 | 2020-09-15 | Arvinas Operations, Inc. | Compounds and methods for the targeted degradation of bromodomain-containing proteins |
| TWI726969B (en) | 2016-01-11 | 2021-05-11 | 比利時商健生藥品公司 | Substituted thiohydantoin derivatives as androgen receptor antagonists |
| EP3455218A4 (en) | 2016-05-10 | 2019-12-18 | C4 Therapeutics, Inc. | C3-carbon linked glutarimide degronimers for target protein degradation |
| EP3481394A1 (en) * | 2016-07-08 | 2019-05-15 | Janssen Pharmaceutica N.V. | Thiohydantoin androgen receptor antagonists for the treatment of cancer |
| TWI739888B (en) | 2016-10-07 | 2021-09-21 | 美商陶氏農業科學公司 | Pesticidal compositions and methods |
| AU2017341723B2 (en) | 2016-10-11 | 2021-12-16 | Arvinas Operations, Inc. | Compounds and methods for the targeted degradation of androgen receptor |
| WO2018089736A1 (en) | 2016-11-10 | 2018-05-17 | Dana-Farber Cancer Institute, Inc. | Degradation of protein kinases by conjugation of protein kinase inhibitors with e3 ligase ligand and methods of use |
| AU2017363257B2 (en) | 2016-11-22 | 2021-08-19 | Dana-Farber Cancer Institute, Inc. | Degradation of protein kinases by conjugation of protein kinase inhibitors with E3 ligase ligand and methods of use |
| RU2747260C2 (en) | 2016-12-19 | 2021-04-29 | Аббиско Тхерапеутицс Цо., Лтд. | Rfrf4 inhibitor, method of its preparation and its pharmaceutical application |
| MX2019009046A (en) | 2017-01-31 | 2019-10-30 | Arvinas Operations Inc | Cereblon ligands and bifunctional compounds comprising the same. |
| CN110769822A (en) | 2017-06-20 | 2020-02-07 | C4医药公司 | N/O-linked degron and degron bodies for protein degradation |
| CN109422725A (en) | 2017-09-04 | 2019-03-05 | 北京美倍他药物研究有限公司 | Drugs for prostate cancer |
| WO2019106691A1 (en) | 2017-11-28 | 2019-06-06 | Aarti Industries Limited | Process for preparation of enzalutamide using novel intermediate |
| WO2019113006A1 (en) | 2017-12-05 | 2019-06-13 | Dow Agrosciences Llc | Pesticidal compositions and methods |
| JP7456945B2 (en) | 2018-05-30 | 2024-03-27 | 江▲蘇▼豪森▲薬▼▲業▼集▲団▼有限公司 | Inhibitors including tricyclic derivatives, their preparation and uses |
| CN109651256A (en) | 2018-11-20 | 2019-04-19 | 上海健康医学院 | A kind of preparation method of the miscellaneous Shandong amine of the grace of formula (VIII) |
| KR20210118816A (en) | 2018-12-19 | 2021-10-01 | 셀진 코포레이션 | Substituted 3-((3-aminophenyl)amino)piperidine-2,6-dione compounds, compositions thereof, and methods of treatment using same |
-
2019
- 2019-12-18 BR BR112021012186-2A patent/BR112021012186A2/en not_active Application Discontinuation
- 2019-12-18 SG SG11202106506WA patent/SG11202106506WA/en unknown
- 2019-12-18 MX MX2021007475A patent/MX2021007475A/en unknown
- 2019-12-18 TW TW108146432A patent/TW202039434A/en unknown
- 2019-12-18 CA CA3124101A patent/CA3124101A1/en active Pending
- 2019-12-18 KR KR1020217022417A patent/KR20210118828A/en unknown
- 2019-12-18 JP JP2021535546A patent/JP2022514347A/en active Pending
- 2019-12-18 CN CN201980092186.9A patent/CN113473987A/en active Pending
- 2019-12-18 WO PCT/US2019/067090 patent/WO2020132016A1/en unknown
- 2019-12-18 AU AU2019404022A patent/AU2019404022A1/en not_active Abandoned
- 2019-12-18 EP EP19899239.8A patent/EP3897635A4/en active Pending
- 2019-12-18 US US16/719,217 patent/US11325889B2/en active Active
-
2021
- 2021-06-20 IL IL284187A patent/IL284187A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU2019404022A1 (en) | 2021-07-08 |
| WO2020132016A1 (en) | 2020-06-25 |
| US20200199074A1 (en) | 2020-06-25 |
| TW202039434A (en) | 2020-11-01 |
| IL284187A (en) | 2021-08-31 |
| EP3897635A4 (en) | 2022-08-31 |
| EP3897635A1 (en) | 2021-10-27 |
| CN113473987A (en) | 2021-10-01 |
| MX2021007475A (en) | 2021-08-05 |
| JP2022514347A (en) | 2022-02-10 |
| BR112021012186A2 (en) | 2021-08-31 |
| CA3124101A1 (en) | 2020-06-25 |
| KR20210118828A (en) | 2021-10-01 |
| US11325889B2 (en) | 2022-05-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL284223A (en) | Substituted 3-((3-aminophenyl)amino)piperidine-2,6-dione compounds, compositions thereof, and methods of treatment therewith | |
| IL284187A (en) | Substituted 3-((3-aminophenyl)amino)piperidine-2,6-dione compounds, compositions thereof, and methods of treatment therewith | |
| MX2023004593A (en) | Tyk2 inhibitors and uses thereof. | |
| IL272748B (en) | 3-(1-oxoisoindolin-2-yl)piperidine-2,6-dione derivatives and uses thereof | |
| IL288278A (en) | Substituted 1-oxo-isoindoline-5-carboxamide compounds, compositions thereof, and methods of treatment therewith | |
| EP3848370A3 (en) | Tyk2 inhibitors and uses thereof | |
| IL262007A (en) | Substituted aminopurine compounds, compositions thereof, and methods of treatment therewith | |
| MX2018009773A (en) | Heteroaryl inhibitors of pad4. | |
| EP4327809A3 (en) | Tyk2 inhibitors and uses thereof | |
| PH12016502523A1 (en) | Crystalline salts of (s)-6-((1-acetylpiperidin-4-yl)amino)-n-(3-(3,4-dihydroisoquinolin-2(1h)-yl)-2-hydroxypropyl)pyrimidine-4-carboxamide | |
| MX2018006700A (en) | Aza-benzimidazole inhibitors of pad4. | |
| IL283968A (en) | Benzamides of pyrazolyl-amino-pyrimidinyl derivatives, and compositions and methods thereof | |
| SG11202011227VA (en) | Compositions comprising bisfluoroalkyl-1,4-benzodiazepinone compounds and methods of use thereof | |
| ZA202007320B (en) | Compounds for pain treatment, compositions comprising same, and methods of using same | |
| MX2021003888A (en) | Novel compounds useful for treating cardiovascular diseases. | |
| IL268318A (en) | Compounds, compositions and uses thereof for improvement of bone disorders | |
| ZA202104192B (en) | Mmpl3 inhibitors, compositions and uses thereof | |
| ZA202006591B (en) | Compositions for the treatment of hypertension | |
| SG10202108825RA (en) | Novel compositions and processes for self-assembly of block copolymers | |
| WO2015138186A3 (en) | Methods and compositions for treating anthracycline-induced cardiomyopathy using neurokinin-1 receptor antagonists | |
| IL281276A (en) | Crystalline (r)-5-carbamoylpyridin-3-yl-2-methyl-4-(3-(trifluoromethoxy)benzyl) piperazine-1-carboxylate, compositions and methods of use thereof | |
| EP3784226A4 (en) | Amide compounds as kinase inhibitors, compositions and methods of treatment | |
| IL284350A (en) | Domperidone compositions and methods for treating depression | |
| EA202191713A1 (en) | SUBSTITUTED 3-((3-AMINOPHENYL)AMINO)PIPERIDINE-2,6-DIONE COMPOUNDS, THEIR COMPOSITIONS AND THEIR TREATMENT METHODS | |
| EA202191712A1 (en) | SUBSTITUTED 3 - ((3-AMINOPHENYL) AMINO) PIPERIDINE-2,6-DIONE COMPOUNDS, THEIR COMPOSITIONS AND METHODS OF TREATMENT WITH THEIR |